Screener
Jazz Pharmaceuticals JAZZ PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses | 149.7 | 152.5 |
| Other current assets | 285.3 | 323.9 |
| Total current assets | 4,583.1 | 4,166.0 |
| Property, plant and equipment, net | 203.1 | 199.9 |
| Operating lease assets | 55.8 | 58.9 |
| Intangible assets, net | 4,203.8 | 4,429.5 |
| Goodwill | 1,805.0 | 1,829.3 |
| Deferred tax assets, net | 907.0 | 869.1 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's PP&E (net)?
- Jazz Pharmaceuticals (JAZZ) reported PP&E (net) of $203.1M in Q1 2026.
- How has Jazz Pharmaceuticals's PP&E (net) changed year-over-year?
- Jazz Pharmaceuticals's PP&E (net) increased by 13.5% year-over-year, from $178.87M to $203.1M.
- What is the long-term trend for Jazz Pharmaceuticals's PP&E (net)?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's PP&E (net) has grown at a 9.3% compound annual growth rate (CAGR), from $127.94M to $199.9M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Jazz Pharmaceuticals's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude